<DOC>
	<DOCNO>NCT02673749</DOCNO>
	<brief_summary>RP-G28 investigate treatment moderate severe lactose intolerance potential improve tolerance lactose ( dairy product ) .</brief_summary>
	<brief_title>Efficacy , Safety , Tolerability Study RP-G28 Subjects With Lactose Intolerance</brief_title>
	<detailed_description>Lactose intolerance common gastrointestinal ( GI ) disorder develop lactose maldigesters consume lactose lactose add previously low-lactose diet . Lactose intolerance characterize one cardinal symptom follow ingestion lactose-containing food . These symptom include ; abdominal pain , cramping , bloating , flatulence [ gas ] diarrhea . As , lactose intolerant individual avoid ingestion milk dairy product , others substitute non-lactose containing product diet . Currently , approve treatment condition . Based health implication insufficient calcium intake lifetime , include increase risk osteoporosis hypertension , need medical community tolerable convenient treatment allow level milk dairy product consumption people suffer mild severe lactose intolerance . Study Objective : To access efficacy two RP-G28 dose regime symptom relate lactose intolerance relative placebo 30 day treatment . The 30 day post-treatment phase evaluate treatment 's potential prolong relief symptom . Study Design : The participant take 60 day complete study . The study consist 3 distinct phase : Screening , 30-day Treatment Phase , 30-day Post-Treatment Phase ( study treatment observation period ) . A participant need visit clinical 6 time throughout study .</detailed_description>
	<mesh_term>Lactose Intolerance</mesh_term>
	<criteria>Inclusion/ Female subject must non pregnant , non lactating . Females childbearing potential must use adequate birth control study participation Medical history intolerance milk dairy product , and/or confirm physician diagnosis lactose intolerance . Must free disorder know associated gastrointestinal disease : irritable bowel syndrome ( IBS ) , inflammatory bowel disease ( IBD ) , ulcerative colitis ( UC ) , Crohn 's disease ( CD ) , Celiac disease , diverticulitis , chronic constipation , chronic pancreatitis , pancreatic insufficiency , symptomatic biliary disease , small intestine bacterial overgrowth syndrome ( SIBO ) , active gastric duodenal ulcer , history severe ulcer . Must nicotine free .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Lactose maldigestion</keyword>
	<keyword>Dairy intolerance</keyword>
	<keyword>Intolerance milk</keyword>
	<keyword>Intolerance dairy</keyword>
	<keyword>Milk intolerance</keyword>
	<keyword>GI disorder</keyword>
	<keyword>Lactose metabolism</keyword>
	<keyword>GI symptom dairy ingestion</keyword>
</DOC>